To start page
2012-5-19 +/-% Buy Sell Latest Volume Turnover (SEK)
NVP -3.42% 10.80 11.30 11.30 20 882 229 958.65
  • Home
  • About NeuroVive
  • Research & Development
  • Investors
  • Contact
Investors
  • Contacts
  • News releases
  • In the News
  • Stock
  • Shareholder reports
  • Corporate governance
  • Analyst coverage
  • Presentations
  • Ownership
  • Calendar
  • Financial calendar
Start / Investors / Financial calendar / Annual report 2011

Annual report 2011

Annual report 2011

  • About NeuroVive
    • In brief
    • Board of Directors
    • Management Team
    • Advisory Board
    • Corporate Governance
    • Partnerships
    • Career
  • Research & Development
    • Project overview
    • Research overview
    • Our products
    • Relevant publications
  • Investors
    • Contacts
    • News releases
    • In the News
    • Stock
    • Shareholder reports
    • Corporate governance
    • Analyst coverage
    • Presentations
    • Ownership
    • Calendar
    • Financial calendar
  • Contact
    • Investors
    • Business development
    • Research

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy